Over the past couple of years BU’s Dr Andrew Mayers in the School of Design, Engineering and Computing, has been working with Bouremouth primary schools to try and reduce sleep problems in school children. Working in schools, sleep is probably the most common problem that is reported by teachers, head-teachers and staff, and Andrew stresses the importance of all children receiving enough sleep to prevent adverse effects on their education and health. He is currently studying the effects of CBD Gummies For Sleep after school staff noticed pupils were struggling to get through the day without falling asleep.
Andrew is currently exploring the possibility of conducting studies that examine the mental health and well-being of children, including how poor sleep affects their emotional, cognitive, social and educational development. He hopes the outcomes will help to offer a clearer understanding of the implications of sleep deprivation in children.
You can read the full TES article here: Can’t sleep, won’t sleep (published 27 July 2012).
Andrew’s research also featured in the Daily Mail: Parents offered ‘get your child to sleep’ classes as pupils turn up to lessons too tired (published 27 July 2012).
Andrew’s website is available here: http://andrewmayers.info/
What do teachers say about the impact of technology on children and young people’s emotions and behaviours?
Conversation article: Why children don’t talk to adults about the problems they encounter online










BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease